自我田野｜我35岁，确诊ADHD三年，仍在与之对抗

Group 1 - ADHD, or Attention Deficit Hyperactivity Disorder, is a neurodevelopmental disorder categorized into three types: ADHD-PI (inattentive), ADHD-HI (hyperactive-impulsive), and ADHD-C (combined) [1] - In China, the prevalence of ADHD among children is approximately 6.26%, equating to around 23 million patients, but the clinical consultation rate is only about 10% [1] - The adult prevalence of ADHD in China is estimated to be around 3% [1] Group 2 - The ADHD treatment market is significant, with a growth rate of 5% annually, representing a market exceeding $10 billion [6] - Central nervous system stimulants are the first-line treatment for ADHD, including medications like methylphenidate and amphetamines, which enhance dopamine and norepinephrine levels [6] - Non-stimulant medications, such as atomoxetine, also play an important role in the market, particularly for patients who cannot tolerate stimulants [6] Group 3 - The diagnosis and treatment of adult ADHD are increasingly recognized, but there are still limited resources available for adult patients in China [14][15] - A map of hospitals capable of diagnosing adult ADHD has been created, highlighting the scarcity of such services [14] - The process of obtaining a diagnosis can be challenging, often requiring multiple consultations and significant financial investment [15][16] Group 4 - The societal perception of ADHD, particularly in women, often leads to underdiagnosis due to the subtler presentation of symptoms [19] - Many adult women with ADHD may have developed compensatory strategies that mask their symptoms, leading to a delay in diagnosis until later in life [19] - The importance of community support and mutual aid groups for individuals with ADHD is emphasized, as they provide a platform for shared experiences and coping strategies [25][27]